Predictive and Experimental Immunogenicity of <i>Burkholderia</i> Collagen-like Protein 8-Derived Antigens
<i>Burkholderia pseudomallei</i> is an infectious bacterium of clinical and biodefense concern, and is the causative agent of melioidosis. The mortality rate can reach up to 50% and affects 165,000 people per year; however, there is currently no vaccine available. In this study, we exami...
Guardado en:
Autores principales: | Megan E. Grund, Eliza Kramarska, Soo Jeon Choi, Dudley H. McNitt, Christopher P. Klimko, Nathaniel O. Rill, Jennifer L. Dankmeyer, Jennifer L. Shoe, Melissa Hunter, David P. Fetterer, Zander M. Hedrick, Ivan Velez, Sergei S. Biryukov, Christopher K. Cote, Rita Berisio, Slawomir Lukomski |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f0325049872148c6b26d2abf44affa70 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Recent Progress in <i>Shigella</i> and <i>Burkholderia pseudomallei</i> Vaccines
por: Itziar Chapartegui-González, et al.
Publicado: (2021) -
Development of a Candidate Multi-Epitope Subunit Vaccine against <i>Klebsiella aerogenes</i>: Subtractive Proteomics and Immuno-Informatics Approach
por: Ahitsham Umar, et al.
Publicado: (2021) -
Development of an Inactivated Vaccine against SARS CoV-2
por: Shaikh Terkis Islam Pavel, et al.
Publicado: (2021) -
SOME WAYS OF PRODUCTION PROCESS OF LIVE PLAGUE VACCINE AND TECHNIQUES OF EVALUATION THE IMMUNOGENICITY (REVIEW)
por: Zh. A. Konovalova, et al.
Publicado: (2013) -
Targets and strategies for vaccine development against dengue viruses
por: Wen-Hung Wang, et al.
Publicado: (2021)